Detecting exposure risk from gene therapy viral vectors
Researchers created an improved method for assays that detect viral vectors in a patient’s blood or urine. It’s used to ensure that bystanders will not be exposed.
DNA
A new addition to the DNA repair toolkit
Nuclear structures that facilitate DNA repair could lead to new cancer therapies.
Synthetic DNA provides a safer blood clot treatment
New potential drug candidates made entirely of synthetic DNA may outperform current available blood clot treatments and avoid the adverse effects.
AI’s role in shaping future therapeutics
Artificial intelligence is helping researchers fill in critical gaps in medical treatment by identifying new drug targets for more precision medicine solutions.
Epigenetic cancer therapy: Targets and strategies
Epigenetic events shape cancer initiation and progression.
By targeting mechanisms involved in epigenetic regulation,
epigenetic therapeutics serve as effective weapons
against cancer.
Assembling genes using in-house oligonucleotide printing
An innovative oligonucleotide synthesis approach streamlines gene assembly, providing researchers with autonomy and efficiency.
Gene editing: DNA versus RNA
Researchers correcting the genetic causes of disease at the DNA or RNA level make their cases.
The Role of Noncoding DNA in Cancer
Intronic DNA sequences are promising targets for developing anti-cancer therapeutics.
Genetic mutations associated with COVID-19 induced loss of smell identified
Researchers use GWAS to understand why some people lose their sense of smell and taste when they are infected with COVID-19.
A new long-read approach solves an old genetic mystery
Researchers pioneered a new strategy for diagnosing puzzling genetic diseases, expanding scientists’ capability to study their causes and pathophysiology.
